Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy,Nano-Micro Letters

当前位置： X-MOL 学术 › Nano-Micro Lett. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Stimuli-Responsive Gene Delivery Nanocarriers for Cancer Therapy
Nano-Micro Letters ( IF 31.6 ) Pub Date : 2023-02-08 , DOI: 10.1007/s40820-023-01018-4
Qingfei Zhang _{1,

2} , Gaizhen Kuang _{1,

2} , Wenzhao Li _{1,

2} , Jinglin Wang ₁ , Haozhen Ren ₁ , Yuanjin Zhao _{1,

3,

4}

Affiliation

Stimuli-responsive gene delivery nanocarriers (GDNCs) possess huge potential in the gene therapy field owing to their effective protection, prolonged blood circulation, selective and targeted delivery, and controlled release of nucleic acid drugs.
Recent advances in stimuli-responsive GDNCs for cancer therapy are classified, summarized, and exhibited by representative examples.
The potential challenges and prospects of stimuli-responsive GDNCs toward clinical translation are outlined and the future research directions are outlooked.

中文翻译：